Starpharma Holdings (ASX:SPL) ROE % Adjusted to Book Value : -32.56% (As of Jun. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Starpharma Holdings ROE % Adjusted to Book Value?

Starpharma Holdings's ROE % for the quarter that ended in Jun. 2024 was -45.59%. Starpharma Holdings's PB Ratio for the quarter that ended in Jun. 2024 was 1.40. Starpharma Holdings's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -32.56%.

Starpharma Holdings ROE % Adjusted to Book Value Historical Data

The historical data trend for Starpharma Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starpharma Holdings ROE % Adjusted to Book Value Chart

Starpharma Holdings Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-2.97

-4.31

-4.66

-10.30

-18.54

Starpharma Holdings Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-4.75	-6.73	-10.64	-2.96	-32.56

Competitive Comparison of Starpharma Holdings's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Starpharma Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Starpharma Holdings's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Starpharma Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Starpharma Holdings's ROE % Adjusted to Book Value falls into.

Starpharma Holdings ROE % Adjusted to Book Value Calculation

Starpharma Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-25.95%	/	1.40
	=	-18.54%

Starpharma Holdings's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-45.59%	/	1.40
	=	-32.56%

Starpharma Holdings ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Starpharma Holdings's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Starpharma Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (ASX:SPL) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

SPHRY:USA SPHRF:USA PQ6:Germany

Address

4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067

Website

https://www.starpharma.com

Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.

Starpharma Holdings Headlines

No Headlines